Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout
Proceedings of the National Academy of Sciences of the United States of America, 06/30/09
Woodward OM et al. – Data suggest that at least 10% of all gout cases in whites are attributable to common SNP rs2231142 in ATP-binding cassette, subfamily G, 2 (ABCG2) gene. With approximately 3 million US individuals suffering from often insufficiently treated gout, ABCG2 represents an attractive drug target.
Methods- GWAS to identify SNPs in a genomic region on chromosome 4 that associate with serum urate levels and gout, a consequence of elevated urate levels
- Functional assays showed that human ABCG2, encoded by the ABCG2 gene is a urate efflux transporter
- Native ABCG2 is located in the brush border membrane of kidney proximal tubule cells, where it mediates renal urate secretion
- Introduction of the mutation Q141K encoded by the common SNP rs2231142 resulted in 53% reduced urate transport rates vs wild-type
- Data from a population-based study of 14,783 individuals support rs2231142 as the causal variant in this region
- It shows highly significant associations with urate levels and gout
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Hepatoprotective effect of TNF-alpha blockade in psoriatic arthritis: A cross-sectional study
Annals of Rheumatic Diseases, 11/09/09
Musculoskeletal manifestations in patients with malignant disease
Clinical Rheumatology, 11/13/09
The relationship between synovial lymphocyte aggregates and the clinical response to infliximab in rheumatoid arthritis: A prospective study
Arthritis & Rheumatism, 11/04/09
Today in Gout and Hyperuricemia...keeping you current
Receive free subspecialty "5-minute updates" via email
Hyperuricemia Is a Mediator of Endothelial Dysfunction and Inflammation in Renal Allograft Recipients
Transplantation Proceedings, 11/02/09
Prescription and comorbidity screening following consultation for acute gout in primary care
Rheumatology, 11/23/09
Common Polymorphisms Influencing Serum Uric Acid Levels Contribute to Susceptibility to Gout, but Not to Coronary Artery Disease
PLoS ONE - Cardiovascular Disorders, 11/10/09
Sponsor
Article Search
Sponsor


See Latest Articles


